DANISH BIOTECH SPV I P/S: Financial statements 2020
CVR: 30274040
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
DANISH BIOTECH SPV I P/S (CVR 30274040) has filed annual accounts for 2020. In 2020, the company reported a gross profit of EUR -31,187 and a net result of EUR -32,410 compared with EUR -576,738 the year before. Equity in the 2020 report amounted to EUR -48,919.
- Gross Profit
- EUR -31,187
- Profit/Loss
- EUR -32,410
- Equity
- EUR -48,919
- Total Assets
- EUR 35,947
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -31K EUR | -32K EUR | -49K EUR | - |
| 2019 | - | -54K EUR | -577K EUR | -17K EUR | - |
| 2018 | - | -39K EUR | -15.2M EUR | 560K EUR | - |
| 2017 | - | -65K EUR | -1.7M EUR | -4.6M EUR | - |
| 2016 | - | -40K EUR | 266K EUR | -2.9M EUR | - |
Official annual report
How creditworthy is DANISH BIOTECH SPV I P/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of October 14, 2020, Kris Allen has left the board of directors of DANISH BIOTECH SPV I P/S.
As of October 14, 2020, Sarah Macknight has left the board of directors of DANISH BIOTECH SPV I P/S.
As of October 14, 2020, Søren Fogh is registered as liquidator of DANISH BIOTECH SPV I P/S.
As of October 14, 2020, John Nathan Bishop has stepped down as chairman of DANISH BIOTECH SPV I P/S.
As of October 14, 2020, Kris Allen has stepped down as director of DANISH BIOTECH SPV I P/S.
On October 14, 2020, DANISH BIOTECH SPV I P/S entered liquidation.
DANISH BIOTECH SPV I P/S has published its annual report for 2019. Gross profit came to DKK -53,907, and the net result was DKK -576,738.
About DANISH BIOTECH SPV I P/S
DANISH BIOTECH SPV I P/S was a Danish company of the type Kommanditaktieselskab/Partnerselskab based in København V, founded in 2007. The company has been dissolved on 26 September 2022. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named DKA I BIOTECH P/S. In 2021, the company reported a gross profit of EUR -25,339 and a net result of EUR 94,239 compared with EUR -32,410 the year before. Equity in the 2021 report amounted to EUR 45,320.
